Dr. Jessica Amelia Tate, MD

Dr. Tate practices at Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina.

Dr. Tate's NPI, 1811159536, was assigned on June 25, 2008. Dr. Tate graduated from West Virginia University School of Medicine in 2008. Dr. Tate holds North Carolina license 2012-01535.

Dr. Tate's primary practice is Davie Surgery - Ophthalmology - HOPD, at 329 Nc Highway 801 N, Bermuda Run, NC 27006.

Dr. Tate's primary practice is Davie Surgery - Ophthalmology - HOPD in Bermuda Run, North Carolina. Dr. Tate is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Tate to 5 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tate practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tate's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tate is licensed in North Carolina.

CMS data shows 425 Medicare services from Dr. Tate across 11 procedure codes in 2024, for 169 Medicare patients. Medicare paid $25,846 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Tate in 2024. The largest group is 75 to 84, with 61 patients. 73% of them have high cholesterol, and 72% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tate's median patient age at 70, with 55% women.

In 2024, Dr. Tate wrote 1,555 Medicare Part D claims for 270 patients. 92% of them were for generic drugs. CMS names the drug for 1,381 of them, across 32 drugs with 11 or more claims each, at $304,890 in total drug cost. In 2023, CMS named 1,511 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Tate for performance year 2024, reported as part of a group. Dr. Tate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tate as offering telehealth.

Dmand AI links 8 papers to Dr. Tate, published from 2011 to 2025. 2015 was the busiest year, with 3. The most frequent topics are Vaccinia virus, Nucleoside-Triphosphatase and Viral Proteins. Dr. Tate has published most often in Virology. Dr. Tate's most frequent co-authors are Roy Ervin Strowd, MD, Ihtsham Ul Haq, MD and Lubna Jafri.

Dmand AI links Dr. Tate to 1 clinical trial. Conditions studied include Constipation and Signs and Symptoms, Digestive.

CMS Open Payments shows 3 general payments to Dr. Tate from 1 drug or device company in 2016. Travel and lodging make up the largest share, 89% of the total. Ipsen Innovation paid the most, $1,085.

Dr. Tate graduated from West Virginia University School of Medicine in 2008.